|
Market Closed -
Toronto S.E.
16:30:00 27/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.0200 CAD | -.--% |
|
-.--% | -20.00% |
| Market Cap | 1.22M 883K 760K 720K 653K 84.32M 1.23M 8.55M 3.29M 42.9M 3.31M 3.24M 136M | P/E 2024 |
-40.5x | P/E 2025 | -5.33x |
|---|---|---|---|---|---|
| Enterprise Value | 2.22M 1.6M 1.38M 1.31M 1.19M 153M 2.24M 15.53M 5.97M 77.91M 6.02M 5.89M 246M | EV / Sales 2024 |
929,496,174x | EV / Sales 2025 | - |
| Free-Float |
53.08% | Yield 2024 * |
-
| Yield 2025 | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| GENX | Delayed | |
OTC Markets
| GENPF | Delayed |
| 1 month | +33.33% | ||
| 3 months | +33.33% | ||
| Current year | -20.00% |
| 1 month | 0.02 | 0.02 | |
| Current year | 0.02 | 0.02 | |
| 1 year | 0.02 | 0.04 | |
| 3 years | 0.02 | 0.09 | |
| 5 years | 0.02 | 0.19 | |
| 10 years | 0.01 | 0.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sina Pirooz
CEO | Chief Executive Officer | 57 | 03/08/2018 |
Raylen Tamayo
DFI | Director of Finance/CFO | - | 04/05/2026 |
Mahmoud Aziz
PSD | President | - | 21/05/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Sina Pirooz
BRD | Director/Board Member | 57 | 03/08/2018 |
Jamie Lewin
BRD | Director/Board Member | 76 | 11/03/2019 |
Kevin Bottomley
BRD | Director/Board Member | 44 | 05/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/9/25 A | Option | Chairman | 1,000,000 | 1.6885% | ||
| 9/9/25 A | Option | Chairman | 1,000,000 | 1.6885% | ||
| 9/9/25 A | Option | Chief Executive Officer | 1,000,000 | 1.6885% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -33.33% | -60.00% | 883K | ||
| -1.13% | -3.11% | +13.82% | +60.17% | 46.21B | ||
| -1.10% | -4.43% | +32.27% | +105.76% | 38.78B | ||
| +0.12% | -0.08% | +7.12% | +73.98% | 11.68B | ||
| -0.53% | -1.37% | -13.25% | +11.19% | 11.55B | ||
| -0.38% | -2.26% | +18.18% | +142.99% | 9.14B | ||
| +0.32% | -2.26% | +23.08% | +35.61% | 7.3B | ||
| +0.17% | -0.74% | +13.44% | +180.68% | 7.15B | ||
| -0.09% | -4.22% | +32.90% | -19.94% | 7.1B | ||
| -3.13% | -4.30% | -44.88% | +12.88% | 4.97B | ||
| Average | -0.58% | -2.33% | +4.94% | +54.33% | 14.39B | |
| Weighted average by Cap. | -0.81% | -3.27% | +15.72% | +74.06% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0 0 0 0 0 0.28 0 0.03 0.01 0.14 0.01 0.01 0.45 | - |
| Net income | -73.2K -52.76K -45.46K -43.04K -39.02K -5.04M -73.57K -511K -197K -2.56M -198K -194K -8.1M | -335K -242K -208K -197K -179K -23.07M -337K -2.34M -900K -11.74M -907K -887K -37.09M |
| Net Debt | 804K 580K 499K 473K 429K 55.38M 808K 5.62M 2.16M 28.18M 2.18M 2.13M 89.03M | 999K 720K 621K 588K 533K 68.82M 1M 6.98M 2.68M 35.01M 2.71M 2.65M 111M |
Employees
4,000
Sector
Pharmaceuticals
- Stock Market
- Stocks
- GENX Stock
Select your edition
All financial news and data tailored to specific country editions

















